860569P

C17 Glucosyl(β) Ceramide (d18:1/17:0)

Avanti Research^™ - A Croda Brand 860569P, powder

• Sinónimos: D-glucosyl-β-1,1′-N-heptadecanoyl-D-erythro-sphingosine
• Fórmula empírica (notación de Hill): C₄₁H₇₉NO₈
• Número de CAS: 1252807-00-3
• Peso molecular: 714.07
• Código UNSPSC: 12352211
• NACRES: NA.25

Propiedades

• formulario: powder
• envase: pkg of 1 × 25 mg (860569P-25mg); pkg of 1 × 5 mg (860569P-5mg)
• fabricante / nombre comercial: Avanti Research^™ - A Croda Brand 860569P
• tipo de lípido: sphingolipids
• Condiciones de envío: dry ice
• temp. de almacenamiento: −20°C
• cadena SMILES: [H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H]([C@H]1CO)O

Descripción

Descripción general

Glucosyl(β) Ceramide (β-GlcCer) is a naturally occurring glycolipid. It is also a ubiquitous intracellular metabolite.

Acciones bioquímicas o fisiológicas

Glucosyl(β) Ceramide (β-GlcCer) regulates the activity of natural killer T (NKT) lymphocytes and displays antimetastatic effects. It is an endogenous macrophage inducible C-type lectin (Mincle) ligand, which exhibits immunostimulatory property. β-GlcCer promotes inflammatory and acquired immune responses on myeloid cells via Mincle. It acts as a potential biomarker for Gaucher′s disease.

Envase

5 mL Amber Glass Screw Cap Vial (860569P-25mg)

5 mL Amber Glass Screw Cap Vial (860569P-5mg)

Información legal

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Información de seguridad

• Código de clase de almacenamiento: 11 - Combustible Solids